Heard

Sign InJoin Heard

Legislative record

HB 1239STATE · TennesseeIntroduced

Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Latest action: Pub. Ch. 295

Voted 4/28/2025

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

Action history

  1. 4/28/2025Effective date(s) 07/01/2025
  2. 4/28/2025Pub. Ch. 295
  3. 4/24/2025Signed by Governor.
  4. 4/16/2025Transmitted to Governor for his action.
  5. 4/14/2025Signed by Senate Speaker
  6. 4/10/2025Signed by H. Speaker
  7. 4/8/2025Enrolled; ready for sig. of H. Speaker.
  8. 4/7/2025Passed Senate, Ayes 27, Nays 4
  9. 4/7/2025Amendment withdrawn. (Amendment 1 - SA0095)
  10. 4/7/2025Senate substituted House Bill for companion Senate Bill.